Associate ProfessorTania Markovic

Clinical Associate Professor

Faculty of Medicine and Health

FUNDED RESEARCH

  • GRANT
    Can a pre-conception weight loss program improve maternal and infant outcomes for women with overweight or obesity? A pragmatic randomised controlled trial (RCT)
    Medical Research Future Fund1 Jun 2020 - 30 Nov 2026
    People funded by this grant:
    • Gordon A,
    • Brand-Miller J,
    • Tarnow-Mordi W,
    • Salis A,
    • Hyett J
  • GRANT
    PreBabe: Can a translatable preconception weight loss program improve outcomes for mothers and babies for women with overweight and obesity A pragmatic randomised controlled trial
    Department of Health and Aged Care (Federal)1 Jun 2020
    People funded by this grant:
  • GRANT
    Improving muscle strength in young people with Prader-Willi syndrome
    Department of Health (Federal)1 Aug 2019 - 31 Mar 2025
    People funded by this grant:
  • GRANT
    Improving weight loss by intermittent use of very low energy diet: the TANGO diet trial Temporary phases of accelerated weight loss for noticeably greater outcomes
    National Health and Medical Research Council (NHMRC)1 Jan 2017 - 31 Dec 2021
    People funded by this grant:
    • Byrne N,
    • Markovic T,
    • Salis (nee Sainsbury) AJ,
    • Seimon R
  • GRANT
    Treating sleep apnoea after weight loss to maintain cardio-metabolic health in the obese with pre-diabetes - A Randomised Controlled Trial
    Diabetes Australia1 Jan 2017
    People funded by this grant:
  • GRANT
    Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Bococizumab (PF-04950615), In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
    Pfizer Australia Pty Ltd1 Sep 2015
    People funded by this grant:
    • Caterson I,
    • Markovic T
  • GRANT
    Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Bococizumab (PF-04950615), In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
    Pfizer Australia Pty Ltd1 Sep 2015
    People funded by this grant:
    • Caterson I,
    • Markovic T
  • GRANT
    Investigation of safety and efficacy of once daily semaglutide in obese subjects without diabetes mellitus. A 52 week, randomised, double-blind, placebo-controlled, nine-armed, parallel group, multi-centre, multinational trial with liraglutide 3.0 mg as a
    Novo Nordisk Pharmaceuticals Pty Ltd1 Jan 2015
    People funded by this grant:
    • Markovic T,
    • Caterson I
  • GRANT
    Randomized, double-blind, placebo controlled, phase 2a trial of ZGN-440 (subcutaneous Beloranib in suspension), a novel methionine aminopeptidase 2 inhibitor, in obese subjects with hypothalamic injury to evaluate weight reduction and safety over 4 weeks f
    Novotech (Australia) Pty Ltd1 May 2014
    People funded by this grant:
    • Caterson I,
    • Markovic T
  • GRANT
    Gold-standard assessment of energy expenditure and aerobic fitness during interventions to prevent diabetes
    Rebecca L Cooper Medical Research Foundation1 Jan 2014
    People funded by this grant:
  • GRANT
    Are eggs good for people with type 2 diabetes
    Australian Eggs1 Jul 2012
    People funded by this grant:
    • Caterson I,
    • Markovic T
  • GRANT
    EXenatide Study of Cardiovascular Event Lowering Trial (EXSCEL) - A randomized, placebo controlled clinical trial to evaluate cardiovascular outcomes after treatment with exenatide once weekly in patients with type 2 diabetes mellitus
    Parexel International (Australia)1 Jul 2011
    People funded by this grant:
    • Caterson I,
    • Markovic T
  • GRANT
    A dietary intervention in gestational diabetes to reduce child obesity: a randomised controlled trial
    National Health and Medical Research Council (NHMRC)1 Jan 2010 - 31 Dec 2013
    People funded by this grant: